Skip to main navigation

Prime Medicine Logo

Overview
News & Events
- Press Releases
- Events & Presentations
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Corporate Governance
Sec filings
IR Resources

Press Releases

Year

September 19, 2023

Prime Medicine to Present at Upcoming Investor Conferences

August 31, 2023

Prime Medicine to Present at Upcoming Investor Conferences

August 7, 2023

Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates

June 22, 2023

Prime Medicine and Cimeio Therapeutics Announce Research Collaboration to Develop Prime Edited Shielded-Cell & Immunotherapy Pairs™ for Genetic Diseases, Acute Myeloid Leukemia and Myelodysplastic Syndrome

May 31, 2023

Prime Medicine to Present at Investor Conferences in June

May 17, 2023

Prime Medicine to Present at Virtual Investor Conferences in May

May 17, 2023

Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting

May 11, 2023

Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates

March 27, 2023

Prime Medicine to Present at Guggenheim Healthcare Talks – Genomic Medicines and Rare Disease Days

March 9, 2023

Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 13

Print Page

Email Alerts

RSS Feeds

Contact IR

prime_

Site - Footer Bottom

Contact Us
Privacy Policy
Terms of Use

© 2021-2023 Prime Medicine, Inc. All rights reserved. PRIME MEDICINE and the Prime Medicine logos are trademarks of Prime Medicine, Inc.